Cartesian Therapeutics, Inc. Operating Cash Flow
Cartesian Therapeutics, Inc. (RNAC) reported Operating Cash Flow of -$43.22 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- Cartesian Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$21.08M.
- Cartesian Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$22.14M.
- Cartesian Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$17.71M.
- Cartesian Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$15.60M, a 213.94% decline year-over-year.
- Cartesian Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$73.94M.
- Cartesian Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$23.67M.
- Cartesian Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$51.16M.
- Cartesian Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$31.63M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$21.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$43.22M 10-Q · filed 2026-08-06 | -$60.93M derived: sum of 3 quarters · filed 2026-08-06 | -$76.53M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | -$22.14M 10-Q · filed 2026-04-30 | -$39.85M derived: sum of 2 quarters · filed 2026-04-30 | -$55.45M derived: sum of 3 quarters · filed 2026-04-30 | -$72.97M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | -$17.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$33.31M derived: sum of 2 quarters · filed 2026-03-09 | -$50.83M derived: sum of 3 quarters · filed 2026-08-06 | -$73.94M 10-K · filed 2026-03-09 | |||
| 2025-09-30 | -$15.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$33.12M derived: sum of 2 quarters · filed 2026-08-06 | -$56.23M 10-Q · filed 2025-11-06 | -$63.23M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | -$17.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$40.63M 10-Q · filed 2026-08-06 | -$47.63M derived: sum of 3 quarters · filed 2026-08-06 | -$33.94M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | -$23.11M 10-Q · filed 2026-04-30 | -$30.11M derived: sum of 2 quarters · filed 2026-04-30 | -$16.42M derived: sum of 3 quarters · filed 2026-04-30 | -$30.86M derived: sum of 4 quarters · filed 2026-04-30 | |||
| 2024-12-31 | -$7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $6.69M derived: sum of 2 quarters · filed 2026-03-09 | -$7.76M derived: sum of 3 quarters · filed 2026-03-09 | -$23.67M 10-K · filed 2026-03-09 | |||
| 2024-09-30 | $13.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$755.00K derived: sum of 2 quarters · filed 2025-11-06 | -$16.67M 10-Q · filed 2025-11-06 | -$39.96M derived: sum of 4 quarters · filed 2025-11-06 | |||
| 2024-06-30 | -$14.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$30.36M 10-Q · filed 2025-08-07 | -$53.65M derived: sum of 3 quarters · filed 2025-08-07 | -$62.86M derived: sum of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | -$15.92M 10-Q · filed 2025-05-08 | -$39.20M derived: sum of 2 quarters · filed 2025-05-08 | -$48.42M derived: sum of 3 quarters · filed 2025-05-08 | -$58.31M derived: sum of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | -$23.29M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$32.50M derived: sum of 2 quarters · filed 2025-03-13 | -$42.40M derived: sum of 3 quarters · filed 2025-03-13 | -$51.16M 10-K · filed 2025-03-13 | |||
| 2023-09-30 | -$9.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$19.11M derived: sum of 2 quarters · filed 2024-11-07 | -$27.88M 10-Q · filed 2024-11-07 | -$39.72M derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | -$9.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$18.66M 10-Q · filed 2024-08-08 | -$30.51M derived: sum of 3 quarters · filed 2024-08-08 | -$26.16M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | -$8.77M 10-Q · filed 2024-05-08 | -$20.61M derived: sum of 2 quarters · filed 2024-05-08 | -$16.26M derived: sum of 3 quarters · filed 2024-05-08 | -$28.53M derived: sum of 4 quarters · filed 2024-05-08 | |||
| 2022-12-31 | -$11.85M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$7.50M derived: sum of 2 quarters · filed 2024-03-07 | -$19.77M derived: sum of 3 quarters · filed 2024-03-07 | -$31.63M 10-K · filed 2024-03-07 | |||
| 2022-09-30 | $4.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$7.92M derived: sum of 2 quarters · filed 2023-11-13 | -$19.78M 10-Q · filed 2023-11-13 | -$51.24M derived: sum of 4 quarters · filed 2024-03-07 | |||
| 2022-06-30 | -$12.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-17 | -$24.14M 10-Q · filed 2023-08-17 | -$55.59M derived: sum of 3 quarters · filed 2024-03-07 | -$66.34M derived: sum of 4 quarters · filed 2024-03-07 | |||
| 2022-03-31 | -$11.86M 10-Q · filed 2023-05-04 | -$43.32M derived: sum of 2 quarters · filed 2024-03-07 | -$54.07M derived: sum of 3 quarters · filed 2024-03-07 | -$60.11M derived: sum of 4 quarters · filed 2024-03-07 | |||
| 2021-12-31 | -$31.46M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$42.21M derived: sum of 2 quarters · filed 2024-03-07 | -$48.25M derived: sum of 3 quarters · filed 2024-03-07 | -$60.38M 10-K · filed 2024-03-07 | |||
| 2021-09-30 | -$10.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$16.79M derived: sum of 2 quarters · filed 2022-11-03 | -$28.92M 10-Q · filed 2022-11-03 | -$36.17M derived: sum of 4 quarters · filed 2023-03-02 | |||
| 2021-06-30 | -$6.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$18.18M 10-Q · filed 2022-08-08 | -$25.43M derived: sum of 3 quarters · filed 2023-03-02 | $40.21M derived: sum of 4 quarters · filed 2023-03-02 | |||
| 2021-03-31 | -$12.13M 10-Q · filed 2022-05-05 | -$19.38M derived: sum of 2 quarters · filed 2023-03-02 | $46.25M derived: sum of 3 quarters · filed 2023-03-02 | $34.45M derived: sum of 4 quarters · filed 2023-03-02 | |||
| 2020-12-31 | -$7.25M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $58.39M derived: sum of 2 quarters · filed 2023-03-02 | $46.58M derived: sum of 3 quarters · filed 2023-03-02 | $34.88M 10-K · filed 2023-03-02 | |||
| 2020-09-30 | $65.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $53.83M derived: sum of 2 quarters · filed 2021-11-09 | $42.13M 10-Q · filed 2021-11-09 | $29.25M derived: sum of 4 quarters · filed 2022-03-10 | |||
| 2020-06-30 | -$11.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$23.51M 10-Q · filed 2021-08-12 | -$36.38M derived: sum of 3 quarters · filed 2022-03-10 | -$47.50M derived: sum of 4 quarters · filed 2022-03-10 | |||
| 2020-03-31 | -$11.70M 10-Q · filed 2021-05-13 | -$24.57M derived: sum of 2 quarters · filed 2022-03-10 | -$35.70M derived: sum of 3 quarters · filed 2022-03-10 | -$42.89M derived: sum of 4 quarters · filed 2022-03-10 | |||
| 2019-12-31 | -$12.88M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$24.00M derived: sum of 2 quarters · filed 2022-03-10 | -$31.20M derived: sum of 3 quarters · filed 2022-03-10 | -$51.44M 10-K · filed 2022-03-10 | |||
| 2019-09-30 | -$11.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$18.32M derived: sum of 2 quarters · filed 2020-11-05 | -$38.56M 10-Q · filed 2020-11-05 | -$51.31M derived: sum of 4 quarters · filed 2021-03-12 | |||
| 2019-06-30 | -$7.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$27.44M 10-Q · filed 2020-08-06 | -$40.19M derived: sum of 3 quarters · filed 2021-03-12 | -$56.22M derived: sum of 4 quarters · filed 2021-03-12 | |||
| 2019-03-31 | -$20.24M 10-Q · filed 2020-05-07 | -$32.99M derived: sum of 2 quarters · filed 2021-03-12 | -$49.02M derived: sum of 3 quarters · filed 2021-03-12 | -$65.99M derived: sum of 4 quarters · filed 2021-03-12 | |||
| 2018-12-31 | -$12.75M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$28.78M derived: sum of 2 quarters · filed 2021-03-12 | -$45.75M derived: sum of 3 quarters · filed 2021-03-12 | -$59.16M 10-K · filed 2021-03-12 | |||
| 2018-09-30 | -$16.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$33.00M derived: sum of 2 quarters · filed 2019-11-08 | -$46.41M 10-Q · filed 2019-11-08 | -$59.07M derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2018-06-30 | -$16.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$30.38M 10-Q · filed 2019-08-08 | -$43.04M derived: sum of 3 quarters · filed 2020-03-12 | -$58.48M derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2018-03-31 | -$13.41M 10-Q · filed 2019-05-09 | -$26.07M derived: sum of 2 quarters · filed 2020-03-12 | -$41.51M derived: sum of 3 quarters · filed 2020-03-12 | -$50.12M derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2017-12-31 | -$12.66M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$28.10M derived: sum of 2 quarters · filed 2020-03-12 | -$36.71M derived: sum of 3 quarters · filed 2020-03-12 | -$52.03M 10-K · filed 2020-03-12 | -$52.04M 10-K · filed 2018-03-15 | ||
| 2017-09-30 | -$15.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$24.05M derived: sum of 2 quarters · filed 2018-11-08 | -$39.37M 10-Q · filed 2018-11-08 | -$37.88M derived: sum of 4 quarters · filed 2019-03-15 | |||
| 2017-06-30 | -$8.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$23.93M 10-Q · filed 2018-08-08 | -$23.93M 10-Q · filed 2017-08-11 | -$22.45M derived: sum of 3 quarters · filed 2019-03-15 | -$27.91M derived: sum of 4 quarters · filed 2019-03-15 | ||
| 2017-03-31 | -$15.32M 10-Q · filed 2018-05-09 | -$15.32M 10-Q · filed 2017-05-11 | -$13.83M derived: sum of 2 quarters · filed 2019-03-15 | -$19.30M derived: sum of 3 quarters · filed 2019-03-15 | -$24.91M derived: sum of 4 quarters · filed 2019-03-15 | ||
| 2016-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | -$3.98M derived: sum of 2 quarters · filed 2019-03-15 | -$9.59M derived: sum of 3 quarters · filed 2019-03-15 | -$19.76M 10-K · filed 2019-03-15 | -$19.68M 10-K · filed 2018-03-15 | ||
| 2016-09-30 | -$5.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$11.07M derived: sum of 2 quarters · filed 2017-11-07 | -$21.24M 10-Q · filed 2017-11-07 | ||||
| 2016-06-30 | -$5.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | -$15.77M 10-Q · filed 2017-08-11 | |||||
| 2016-03-31 | -$10.17M 10-Q · filed 2017-05-11 | ||||||
| 2015-12-31 | -$22.46M 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |